TransUnion (TRU) Stock News

Rosen Law Firm announces a July 28, 2026 deadline for investors to join a securities class action against Lucid Group, Inc. The lawsuit alleges that Lucid made false statements regarding supplier quality issues that disrupted Gravity deliveries and overstated manufacturing capabilities, resulting in material negative impact on the company's business and financial results.

A securities class action lawsuit has been filed against Zoetis Inc. for allegedly making false and misleading statements about its Companion Animal products during January 14, 2025 to May 6, 2026. The lawsuit claims the company failed to disclose weakening veterinarian adoption of its Librela pain treatment following FDA safety warnings, significant market share losses in Simparica Trio to competitors, and declining market share in dermatology products Apoquel and Cytopoint. Investors with losses exceeding $100,000 are encouraged to join the class action before the July 27, 2026 lead plaintiff deadline.

Rosen Law Firm has issued multiple securities class action deadline alerts for investors. The primary case involves Sportradar Group AG (SRAD), where investors who purchased shares between November 7, 2024 and April 21, 2026 may be entitled to compensation. The lawsuit alleges that Sportradar made false statements about compliance and worked with black-market gambling operators while claiming strict regulatory adherence. The lead plaintiff deadline is July 17, 2026. Similar deadline alerts were also issued for FS KKR Capital Corp. (FSK) and Regencell Bioscience Holdings Limited (RGC).

Rosen Law Firm has filed class action lawsuits on behalf of investors in GRAIL, Inc. and other companies. The GRAIL lawsuit alleges that defendants made materially false and misleading statements regarding the NHS-Galleri trial results, concealing that the trial period was insufficient to demonstrate the primary endpoint of reducing Stage III-IV cancers. Investors who purchased GRAIL stock between May 13, 2025 and February 19, 2026 may be eligible for compensation. The lead plaintiff deadline is August 4, 2026.

Rosen Law Firm has filed a class action lawsuit against Roblox Corporation on behalf of investors who purchased common stock between October 30, 2025 and April 30, 2026. The lawsuit alleges that Roblox provided misleading statements about its organic growth potential while concealing material adverse facts, including a significant slowdown in growth rates due to age verification rollout impacts, reduced on-platform communication, and declining app store ratings. Investors who suffered damages may be entitled to compensation.

A securities class action lawsuit has been filed against Babcock & Wilcox Enterprises, Inc. for allegedly making false and misleading statements regarding a Power Generation contract with Applied Digital. The lawsuit claims that B&W's largest shareholder BRC Group Holdings stood on both sides of the contract and that Applied Digital did not actually need the products/services, raising questions about revenue recognition and overstating business prospects. Investors who purchased B&W securities between November 5, 2025 and March 11, 2026 may be eligible for compensation.

Rosen Law Firm has filed a class action lawsuit against Helen of Troy Limited on behalf of investors who purchased common stock between April 24, 2024 and October 8, 2025. The lawsuit alleges misrepresentations regarding Project Pegasus, a restructuring program, where the company assured investors of progress despite acknowledged implementation issues with its Tennessee distribution center. The lead plaintiff deadline is August 3, 2026.

Rosen Law Firm has filed a class action lawsuit against Via Transportation, Inc. (NYSE: VIA) on behalf of IPO investors, alleging that offering documents were false and misleading. The complaint claims Via omitted material facts about declining Platform Annual Run-Rate Revenue and inability to grow in Germany. Via's stock has declined approximately 70% from its IPO price to $14.52, and investors are encouraged to join the class action before the August 10, 2026 deadline to serve as lead plaintiff.

Rosen Law Firm has filed a class action lawsuit against BitGo Holdings, Inc. on behalf of investors who purchased securities during the company's January 2026 IPO and through May 2026. The lawsuit alleges that BitGo's offering documents contained materially false and misleading statements, specifically understating risks related to declining digital asset prices and their impact on the company's financial performance. Investors must move the court by August 7, 2026 to serve as lead plaintiff.

Universal Health Realty Income Trust (NYSE:UHT) announced that its Board of Trustees voted to increase the quarterly dividend by $0.005, with a new dividend of $0.75 per share payable on June 30, 2026 to shareholders of record as of June 22, 2026.

A securities class action lawsuit has been filed against Sportradar Group AG (NASDAQ: SRAD) alleging the company made false statements about compliance and ethics while secretly working with black-market gambling operators. Investors who purchased shares between November 7, 2024 and April 21, 2026 may be eligible for compensation. The deadline to serve as lead plaintiff is July 17, 2026.

Rosen Law Firm is notifying investors in Medpace Holdings, Upstart Holdings, and Babcock & Wilcox Enterprises of securities class action lawsuits. The firm alleges that Medpace made false statements about backlog cancellation rates and provided misleading growth projections. Investors with losses exceeding $100,000 are encouraged to secure counsel before the June 8, 2026 deadline to potentially serve as lead plaintiffs.

Rosen Law Firm announces a securities class action lawsuit against Babcock & Wilcox Enterprises (B&W) for allegedly making false and misleading statements regarding a Power Generation contract with Applied Digital. The lawsuit claims B&W's largest shareholder BRC Group Holdings stood on both sides of the contract and that Applied Digital did not actually need B&W's products, raising questions about revenue recognition. The lead plaintiff deadline is June 15, 2026.

Rosen Law Firm is soliciting investors for multiple securities class action lawsuits. The primary case involves Sportradar Group AG, where investors who purchased shares between November 7, 2024 and April 21, 2026 may be entitled to compensation. The lawsuit alleges Sportradar made false statements about compliance and worked with black-market gambling operators while misrepresenting its KYC processes. Additional class actions are mentioned for ChampionX Corporation and Futu Holdings Limited. The lead plaintiff deadline for Sportradar is July 17, 2026.

Rosen Law Firm is encouraging investors who purchased securities of Commvault Systems, Calix, Inc., and Wise Group plc during specified periods to join class action lawsuits. The Commvault lawsuit alleges the company made materially false statements regarding ARR growth guidance and concealed material adverse facts. Lead plaintiff deadlines and contingency fee arrangements are available for eligible investors.

Rosen Law Firm announces a securities class action lawsuit against Medpace Holdings, Inc. for allegedly making false statements about backlog cancellation rates and providing misleading growth projections. Investors who purchased MEDP stock between April 22, 2025 and February 9, 2026 may be eligible for compensation. The deadline to serve as lead plaintiff is June 8, 2026.

Rosen Law Firm is notifying investors in Babcock & Wilcox Enterprises, Aldeyra Therapeutics, and ChampionX Corporation of ongoing securities class action lawsuits. The B&W lawsuit alleges the company made false statements regarding a Power Generation contract with Applied Digital, with its largest shareholder BRC standing on both sides of the deal. Investors with losses exceeding $100K are encouraged to secure counsel before upcoming deadlines.

Rosen Law Firm is urging investors who purchased Upstart Holdings (NASDAQ: UPST) securities between May 14, 2025 and November 4, 2025 to join a class action lawsuit. The lawsuit alleges that Upstart made false statements about its Model 22 AI risk assessment tool, claiming it frequently overreacted to negative economic signals, overstated accuracy, and negatively impacted revenue guidance. The lead plaintiff deadline is June 8, 2026.

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ WINNIPEG, MB , May 21, 2026 /CNW/ - Marwest Apartment Real Estate Investment Trust (the "REIT" ) (TSXV: MAR ) reported financial results for the three months ended March 31, 2026. This press release should be read in conjunction with the REIT's Unaudited Condensed Consolidated Interim Financial Statements and Management's Discussion and Analysis ( " Q1 2026 MD&A " ) for the three months ended March 31, 2026, which are available on the REIT's website at www.marwestreit.com and at www.sedarplus.ca . "Q1 has shown stable occupancy with rental increases of 1.9% over the same period last year. We anticipate continued modest increases throughout the remainder of 2026, due to reduced immigration and non-renewal of existing non-resident visa's" commented Mr. William Martens, Chief Executive Officer of the REIT. Q1 2026 Quarterly Highlights Same Property Revenue increased by 2.22% in the three months ended March 31, 2026 compared to same period 2025 $79,261 of positive cash was generated during the three months ended March 31, 2026 Reported Net Asset Value per Unit (" NAV ") of $2.47 at March 31, 2026 compared to $2.46 at December 31, 2025 Average occupancy rate of 98.37% reported for the three months ended March 31, 2026 in line with 98.14% in the same period 2025 Operations Summary Three months ended March 31 Portfolio Operation Information 2026 2025 Number of properties 4 4 Number of suites 516 516 Average occupancy ate 98.37 % 98.14 % Average rental rate to date $1,760 $1,727 Three months ended March 31 Reconciliation of Same Property NOI 1 to IFRS 2026 2025 Revenue from investment properties $ 2,694,078 $ 2,635,142 Expenses: Property operating expenses 693,151 694,292 Realty taxes 357,204 317,432 Total property operating expenses 1,050,355 1,011,724 Same Property NOI 1

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Gossamer Bio, Inc., where defendants allegedly made false statements about their Phase 3 PROSERA study design, particularly regarding placebo response controls at Latin American testing sites. Investors who purchased securities during the Class Period (June 16, 2025 - February 20, 2026) may be eligible for compensation. The lead plaintiff deadline is June 1, 2026.

VALENCIA, Spain, May 18, 2026 (GLOBE NEWSWIRE) -- Turbo Energy, S.A. (NASDAQ: TURB ) ("Turbo Energy" or the "Company"), a global integrator of AI-driven solar energy storage solutions and intelligent energy management systems, today announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission ("SEC"). Turbo Energy reported full year 2025 revenue of $23.46 million, representing year-over-year growth of 107% compared to 2024. The Company also reported a significant improvement in operating performance, with operating loss decreasing to $0.91 million compared to $4.11 million in the prior year, while net loss decreased to $1.36 million compared to $3.45 million in 2024. During early 2026, Turbo Energy further strengthened its financial position through approximately $5.0 million in aggregate gross proceeds raised through a Registered Direct Offering ("RDO") and issuances under its "at-the-market" ("ATM") program. These transactions significantly reinforced the Company's balance sheet and increased shareholders' equity by approximately $4.6 million, from approximately $1.88 million¹ in 2025 to approximately $6.48 million in 2026, positioning the Company well above Nasdaq's minimum stockholders' equity requirement for continued listing. 2025 marked a decisive operational and strategic inflection point for Turbo Energy, as the Company accelerated its transition from a traditional energy storage provider into an AI-driven intelligent energy infrastructure platform focused on software-defined energy management, advanced storage integration and high-value commercial and industrial ("C&I") deployments. Throughout 2025, Turbo Energy continued expanding its positioning as a technology integrator capable of combining solar generation, advanced battery storage and propriet

The global industrial laser market is projected to grow from $7.8 billion in 2025 to $10.94 billion by 2031 at a CAGR of 5.80%. Medium power lasers and CO₂ lasers lead the market, with cutting applications dominating. The semiconductor and electronics sector shows the fastest growth at 7.14% CAGR. APAC retains 53% market share, while India is expected to register the highest regional CAGR. Key trends include integration with quality control systems, visible-wavelength lasers for copper applications, and automation-ready platforms. Market restraints include capital cycle sensitivity and pricing pressure in mature segments.

Rosen Law Firm is reminding investors in Gossamer Bio, ImmunityBio, and Immutep Ltd. about upcoming deadlines to join securities class action lawsuits. The lawsuits allege that defendants made false and misleading statements to investors, with Gossamer Bio specifically accused of concealing material adverse facts concerning its Phase 3 PROSERA study design. Investors who purchased securities during specified class periods may be eligible for compensation.

Brookfield Bancshares, Inc. and First National Bank of Brookfield announced the execution of a definitive merger agreement to acquire NSTS Bancorp, Inc. and North Shore Trust and Savings in an all-cash transaction valued at approximately $73.7 million. NSTS stockholders will receive $14.28 per share in cash. The transaction is expected to close in Q4 2026, subject to regulatory approvals and stockholder approval. Post-closing, the combined entity will operate four branches in the Chicago-Naperville-Elgin MSA with over $600 million in assets.

Rosen Law Firm is reminding investors who purchased Stellantis N.V. common stock between February 26, 2025 and February 5, 2026 of the June 8, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Stellantis made false statements about its earnings growth potential and electrification strategy, and concealed material facts about its inability to capitalize on EV opportunities, ultimately requiring significant charges to shift away from battery-powered electric vehicles.

Erasca announced a clinical trial collaboration and supply agreement with Merck to evaluate ERAS-0015, a pan-RAS molecular glue, in combination with Merck's pembrolizumab (KEYTRUDA®) for treating RAS-mutant solid tumors. The AURORAS-1 Phase 1 trial showed favorable safety, tolerability, and clinical responses at low doses. Merck will supply pembrolizumab at no cost to support the proof-of-concept study.

Rosen Law Firm is encouraging investors who purchased securities of Lufax Holding Ltd between April 7, 2023 and January 26, 2025 to join a securities class action lawsuit. The lawsuit alleges that Lufax made false and misleading statements regarding its internal controls and financial results. The firm is also investigating potential securities claims for ADMA Biologics and Super Micro Computer in

Rosen Law Firm is notifying investors in Concorde International Group Ltd. (CIGL), Franklin BSP Realty Trust, Inc. (FBRT), and ODDITY Tech Ltd. (ODD) of upcoming deadlines to join securities class action lawsuits. The lawsuits allege fraudulent activities, including false statements, misleading disclosures, and coordinated stock manipulation schemes.